Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
Go back to Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026| (NASDAQ: PSNL) | Delayed: 10.06 -0.11 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.17 | 52 Week High | $ | |||
| Open | $9.88 | 52 Week Low | $ | |||
| Day High | $10.56 | P/E | N/A | |||
| Day Low | $9.76 | EPS | $ | |||
| Volume | 1,204,526 | |||||

